TC
UTMD icon

TFS Capital’s Utah Medical Products UTMD Stock Holding History

TFS Capital’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,226
Closed -$234K – 346
2017
Q2 		$234K Buy
+3,226
New +$212K 0.09% 399
2016
Q3 		– Sell
-16,643
Closed -$1.05M – 989
2016
Q2 		$1.05M Buy
16,643
+3,292
+25% +$212K 0.19% 166
2016
Q1 		$835K Buy
+13,351
New +$787K 0.12% 305

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

TFS Capital's UTMD Position: Q3 2017 in Review

TFS Capital sold out of Utah Medical Products (UTMD) in Q3 2017, closing a stake of 3,226 shares — an estimated $234K sold.

TFS Capital first reported a position in UTMD in Q1 2016 and held it in 3 quarters. The position peaked at $1.05M in Q2 2016. 74 funds tracked by Wall St. Rank hold UTMD as of Q3 2017.

  • TFS Capital reported no remaining Utah Medical Products position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 3,226 Utah Medical Products shares in Q3 2017, an estimated $234K.
  • TFS Capital first reported a position in Utah Medical Products in Q1 2016 and held it in 3 quarters.
  • TFS Capital's Utah Medical Products position peaked at $1.05M in Q2 2016.
  • 74 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.